{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "INTERCEPT PHARMAC.DL-,001", "longName": "Intercept Pharmaceuticals, Inc.", "messageBoardId": "finmb_11382658", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": -2.3472502, "regularMarketPrice": 14.145, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.31, "epsForward": -5.08, "epsCurrentYear": -4.08, "priceEpsCurrentYear": -3.466912, "sharesOutstanding": 41687100, "bookValue": 1.612, "fiftyDayAverage": 15.2745, "fiftyDayAverageChange": -1.1294994, "fiftyDayAverageChangePercent": -0.07394674, "twoHundredDayAverage": 15.21425, "twoHundredDayAverageChange": -1.0692492, "twoHundredDayAverageChangePercent": -0.07027946, "marketCap": 603929280, "forwardPE": -2.7844489, "priceToBook": 8.774815, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.7 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1350626400000, "priceHint": 2, "regularMarketChange": -0.3399992, "regularMarketTime": 1683892036, "regularMarketDayHigh": 14.145, "regularMarketDayRange": "14.065 - 14.145", "regularMarketDayLow": 14.065, "regularMarketVolume": 270, "regularMarketPreviousClose": 14.485, "bid": 14.185, "ask": 14.68, "bidSize": 40, "askSize": 40, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 14.075, "averageDailyVolume3Month": 34, "averageDailyVolume10Day": 149, "fiftyTwoWeekLowChange": 3.5900002, "fiftyTwoWeekLowChangePercent": 0.34012318, "fiftyTwoWeekRange": "10.555 - 20.0", "fiftyTwoWeekHighChange": -5.8549995, "fiftyTwoWeekHighChangePercent": -0.29274997, "fiftyTwoWeekLow": 10.555, "fiftyTwoWeekHigh": 20.0, "earningsTimestamp": 1682598600, "earningsTimestampStart": 1690893000, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "symbol": "I4P.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "305 Madison Avenue", "city": "Morristown", "state": "NJ", "zip": "07960", "country": "United States", "phone": "646 747 1000", "website": "https://www.interceptpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis and NASH; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in Morristown, New Jersey.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jerome B. Durso", "age": 54, "title": "Pres, CEO & Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 1160689, "fmt": "1.16M", "longFmt": "1,160,689"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andrew  Saik", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 485074, "fmt": "485.07k", "longFmt": "485,074"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rocco  Venezia", "age": 46, "title": "Chief Accounting Officer & Treasurer", "yearBorn": 1976, "fiscalYear": 2021, "totalPay": {"raw": 660625, "fmt": "660.62k", "longFmt": "660,625"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 54, "title": "Gen. Counsel", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 691464, "fmt": "691.46k", "longFmt": "691,464"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. M. Michelle Berrey M.D., M.P.H., MPH.", "age": 55, "title": "Pres of R&D and Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2021, "totalPay": {"raw": 732131, "fmt": "732.13k", "longFmt": "732,131"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nareg  Sagherian", "title": "Exec. Director of Global Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Ford", "age": 52, "title": "Chief HR Officer", "yearBorn": 1970, "fiscalYear": 2017, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mark  Pruzanski M.D.", "age": 54, "title": "Founder, Advisor & Director", "yearBorn": 1968, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Linda M. Richardson", "age": 58, "title": "Exec. VP & Chief Commercial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Paul  Nitschmann", "title": "Sr. VP of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 4, "shareHolderRightsRisk": 6, "overallRisk": 5, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}